Cite
HARVARD Citation
Powell, R. et al. (n.d.). Durvalumab for stage III non-small cell lung cancer (NSCLC): early access programme (EAP) in University Hospitals Birmingham (UHB), UK. Lung cancer. pp. S47-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Powell, R. et al. (n.d.). Durvalumab for stage III non-small cell lung cancer (NSCLC): early access programme (EAP) in University Hospitals Birmingham (UHB), UK. Lung cancer. pp. S47-. [Online].